Dr. Falk Pharma
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 3/1/2025
Pipeline by Phase
Therapeutic Focus
Clinical Trials (29)
Once Daily Versus Twice Daily Budesonide Orodispersible Tablets for Induction of Remission in EoE
Started: 5/21/2021
Study with Norucholic Acid Tablets in Patients with Primary Sclerosing Cholangitis (PSC)
Started: 3/1/2025
norUrsodeoxycholic Acid vs Placebo in PSC
Started: 2/8/2018
Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis
Started: 1/15/2016
Budesonide for Induction of Remission in Incomplete Microscopic Colitis
Started: 5/1/2014
Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC)
Started: 2/1/2009
Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2)
Started: 10/1/2014
Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea
Started: 11/1/2010
Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis
Started: 5/1/2010
Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis
Started: 1/1/2008
Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis
Started: 1/1/2010
Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis
Started: 7/21/2014
Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis
Started: 11/11/2015
TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC)
Started: 1/1/2013
Efficacy and Safety Study of Budesonide to Treat Oral Chronic Graft vs Host Disease (cGvHD)
Started: 3/1/2009
9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease
Started: 11/1/2009
Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease
Started: 6/10/2024
Different Doses of Naronapride vs. Placebo in Gastroparesis
Started: 1/3/2023
Mesalazine Oral Suspension in Active Eosinophilic Esophagitis
Started: 2/9/2023
Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis
Started: 9/1/2013
Rifamycin SV-MMX® 400 mg b.i.d. vs. Rifamycin SV-MMX® 600 mg t.i.d. vs. Placebo in Acute Uncomplicated Diverticulitis
Started: 8/1/2013
Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis
Started: 12/1/2012
Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis
Started: 6/1/2011
Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease
Started: 11/1/2010
Budesonide Foam Versus Placebo for Prevention of Acute Radiation Proctitis
Started: 9/1/2008
Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis
Started: 11/1/2008